GENERAL29 Sept 2026
US exempts India, 19 other nations from 100% tariff on speciality drugs
The US will not charge its 100 per cent tariff on certain speciality drugs and ingredients coming from India and 19 other countries. The zero rate covers medicines for rare diseases, infertility, cell and gene therapies, and animal drugs. Generic drugs stay outside these tariffs. The 100 per cent tariff starts September 29 for other covered companies. If you export such products, check your paperwork before shipping.
Key Statutory Highlights
- The US has exempted India and 19 other countries from the 100 per cent tariff on certain speciality drugs and their components.
- The zero per cent rate covers drugs for rare diseases, infertility treatments, cell therapies, gene therapies, antibody-drug conjugates and animal pharmaceuticals.
- Generic pharmaceutical products and their associated ingredients are not subject to the Section 232 pharmaceutical tariffs.
Actionable Advice for Taxpayers / Founders:If you export speciality medicines or their ingredients to the US, compare your product list with the US Commerce Department notice in the Federal Register and check with your customs broker before your next shipment. Treat this as general information, not a confirmed legal position for your goods.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: